Related Experiment Videos
Depression of lymphocyte reactivity by serum from patients with dilated cardiomyopathy
Insights
Serum factors inhibiting lymphocyte response are elevated in dilated cardiomyopathy patients, correlating with heart failure severity. This suggests a potential T-suppressor defect contributing to disease progression.
Area of Science:
- Immunology
- Cardiology
- Cellular Biology
Background:
- Dilated cardiomyopathy (DCM) is a complex heart condition.
- Immune system dysregulation may play a role in DCM pathogenesis.
- Specific serum factors affecting lymphocyte function in DCM are not well understood.
Purpose of the Study:
- To investigate the presence and levels of serum inhibitory factors in patients with dilated cardiomyopathy.
- To determine the correlation between these serum factors and disease severity.
- To explore the potential impact on lymphocyte function.
Main Methods:
- Assessed serum inhibitory factor and rosette inhibitory factor levels in DCM patients.
- Compared levels to control disease and normal subject groups.
- Correlated factor levels with New York Heart Association functional classification.
- Evaluated other immunological parameters (IgG, IgA, IgM, C3, C4, alpha-2-macroglobulin).
Main Results:
- Serum inhibitory factors were significantly higher in DCM patients compared to controls (P<0.05) and normal subjects (P<0.02).
- Elevated factors correlated significantly with cardiac failure functional class (P<0.05).
- No correlation was found with other tested immunological markers.
Conclusions:
- Patients with dilated cardiomyopathy exhibit increased serum inhibitory factors.
- These factors may contribute to a T-suppressor functional defect.
- The presence of these factors is linked to greater disease severity in DCM.
Abstract:
We have investigated the presence of serum factors (serum inhibitory factor and rosette inhibitory factor) which inhibit the blastogenic response to phytohemagglutinin and E-rosette function of normal lymphocytes in patients affected with dilated cardiomyopathy. We found them to be present in significantly higher levels with respect to a "control disease" group (P less than 0.05) and normal subjects (P less than 0.02). Furthermore, serum inhibitory factors were significantly correlated to the functional class of cardiac failure as evaluated according to the New York Heart Association functional classification (P less than 0.05). There was no correlation between serum factors and other immunological parameters investigated (serum IgG, IgA, IgM, C3 and C4 concentrations, alpha-2-macroglobulin levels). Serum inhibitory factors may affect lymphocyte subpopulations, accounting for a T-suppressor functional defect correlated with greater severity of the disease.